shigellosi
one
common
caus
diarrhea
human
worldwid
annual
number
shigella
episod
throughout
world
estim
million
million
occur
develop
nation
result
million
death
kotloff
et
al
human
primat
natur
reservoir
shigella
speci
niyogi
epidem
usual
occur
crowd
area
poor
sanitari
condit
transmiss
person
person
common
food
water
contamin
organ
despit
econom
public
health
improv
outbreak
shigellosi
still
report
regularli
anonym
b
gaynor
et
al
kuo
et
al
marcu
et
al
morgan
et
al
wei
et
al
definit
diagnosi
shigellosi
made
isol
organ
stool
sampl
china
shigellosi
rank
third
morbid
follow
tuberculosi
hepat
becom
number
caus
diseaserel
death
children
cdc
mather
et
al
histor
subgroup
shigella
describ
subgroup
dysenteria
subgroup
b
flexneri
subgroup
c
boydii
subgroup
sonnei
among
subgroup
epidem
subgroup
diarrhea
typic
sonnei
industri
countri
flexneri
develop
countri
includ
beij
area
mani
year
gupta
et
al
kotloff
et
al
qu
et
al
von
seidlein
et
al
howev
case
sonnei
notic
increas
sonnei
becom
domin
subgroup
asian
countri
recent
year
bangtrakulnonth
et
al
fillioltoutain
et
al
kotloff
et
al
mamishi
et
al
orrett
qu
et
al
salmanzadehahrabi
et
al
wei
et
al
necessari
explor
clinic
import
sonneirel
infect
caus
systemat
infect
bacteriemia
mening
immunocompromis
individu
chapel
et
al
addit
sonnei
often
associ
intern
foodborn
infect
outbreak
airlin
passeng
import
food
travel
anim
insect
vector
sonnei
also
sexual
transmit
among
homosexu
male
anonym
anonym
gaynor
et
al
kuo
et
al
marcu
et
al
morgan
et
al
okek
edelman
salam
bennish
sonnei
remain
public
health
concern
becom
threat
develop
develop
nation
prompt
treatment
effect
antimicrobi
agent
may
shorten
durat
clinic
symptom
excret
pathogen
well
decreas
carriag
sever
transmiss
dysenteri
sonnei
salam
bennish
howev
progress
increas
antimicrobi
resist
especi
multidrug
resist
among
shigella
antibiot
due
overus
antibiot
develop
countri
becom
critic
problem
salmanzadehahrabi
et
al
addit
subgroup
distribut
antimicrobi
resist
pattern
among
shigella
spp
vari
region
region
even
within
region
wong
et
al
correct
treatment
prompt
control
shigellosi
depend
recognit
domin
preval
shigella
subgroup
serotyp
well
relat
antimicrobi
resist
profil
local
region
epidem
trend
resist
clonal
transmiss
sonnei
isol
studi
china
well
report
studi
evalu
epidemiolog
shigella
serogroup
antibiot
resist
pattern
preval
clonal
transmiss
relat
risk
factor
sonnei
strain
circul
beij
region
year
januari
decemb
fresh
stool
specimen
collect
diarrhea
patient
clinic
suspect
dysenteri
submit
microbiolog
laboratori
hospit
peopl
liber
armi
beij
china
infecti
diseas
teach
hospit
sampl
cultur
shigella
streak
directli
onto
salmonellashigella
ss
agar
tian
tan
biolog
technolog
compani
china
incub
overnight
colorless
semitranspar
smooth
moist
circular
coloni
screen
ss
agar
streak
kligler
iron
agar
ye
et
al
shigella
strain
identifi
accord
biochem
characterist
nataro
et
al
serotyp
shigella
isol
determin
commerci
variabl
polyclon
monoclon
antisera
shigella
serotyp
slide
agglutin
method
accord
manufactur
instruct
japan
institut
health
diagnost
serum
shigella
japan
shigella
isol
per
patient
per
diarrhea
episod
includ
analysi
vitro
activ
ampicillin
amp
piperacillin
pip
ceftriaxon
cro
cefepim
fep
ciprofloxacin
cip
norfloxacin
ofloxacin
ofx
levofloxacin
lvx
cefmetazol
cmz
chloramphenicol
chl
sulfamethoxazoletrimethoprim
sxt
fosfomycin
fo
determin
kirbybau
discdiffus
method
accord
guidelin
perform
standard
antimicrobi
suscept
test
recommend
clinic
laboratori
standard
institut
clsi
escherichia
coli
atcc
strain
use
qualiti
control
strain
result
interpret
either
sensit
intermedi
resist
studi
consid
intermedi
resist
result
resist
clonal
transmiss
pattern
determin
pulsedfield
gel
electrophoresi
pfge
describ
previous
qu
et
al
briefli
genom
dna
extract
logarithmicphas
cultur
prepar
lowmeltingpoint
agaros
plug
digest
restrict
enzym
xbai
takara
shiga
japan
accord
standard
procedur
electrophoresi
perform
biorad
chef
dr
ii
system
biorad
hercul
ca
usa
pfge
run
condit
v
switch
h
along
specimen
dna
salmonella
serotyp
braenderup
strain
digest
xbai
use
molecular
weight
standard
gel
electrophoresi
gel
stain
ethidium
bromid
rins
photograph
uv
light
band
pattern
isol
evalu
pfge
compar
visual
inspect
isol
group
suggest
naubol
et
al
isol
defin
epidem
one
belong
genotyp
identifi
least
individu
statist
comparison
perform
epi
info
softwar
version
center
diseas
control
prevent
atlanta
ga
usa
categor
data
express
percentag
calcul
use
chisquar
test
p
valu
calcul
p
consid
statist
signific
studi
period
total
shigella
strain
isol
diarrhea
patient
among
sonnei
isol
came
male
femal
age
rang
month
year
old
mean
sd
year
children
less
year
old
account
studi
patient
death
reveal
inpati
outpati
sonnei
isol
recov
dominantli
summer
season
winter
decemb
januari
februari
spring
march
april
may
summer
june
juli
august
fall
septemb
octob
novemb
respect
sonnei
subgroup
respons
shigellosi
case
year
respect
contrast
flexneri
group
respons
respect
start
sonnei
replac
flexneri
becom
domin
subgroup
beij
area
fig
b
resist
rate
sonnei
isol
amp
pip
cro
fep
cip
ofx
lvx
cmz
chl
sxt
fo
respect
resist
rate
sonnei
amp
pip
cro
fep
p
sxt
p
fo
p
chang
significantli
research
period
p
tabl
addit
multidrugresist
sonnei
isol
defin
resist
antibiot
agent
subclass
determin
amp
pip
sxt
amp
pip
cro
amp
pip
cro
fep
none
antimicrobi
agent
effect
strain
among
sonnei
isol
phase
phase
ii
isol
respect
base
pfge
analysi
determin
epidem
clone
divid
subtyp
fig
fig
year
unusu
due
sever
acut
respiratori
syndrom
sar
outbreak
region
antibiot
resist
rate
sonnei
isol
vari
among
differ
pfge
subtyp
especi
antibiot
shown
tabl
amp
pip
resist
rate
subtyp
group
p
p
p
p
statist
higher
resist
rate
cro
highest
clone
statist
higher
clone
p
clone
p
clone
p
even
fourthgener
cephalosporin
fep
resist
clone
statist
higher
clone
p
clone
p
tabl
among
factor
origin
depart
sourc
sex
age
diarrheal
patient
subtyp
observ
significantli
higher
frequenc
inpati
pfge
subtyp
p
tabl
studi
present
antibiot
resist
genotyp
profil
clinic
sonnei
isol
circul
period
beij
area
data
show
decreas
frequenc
shigella
infect
case
except
due
improv
econom
situat
environment
condit
hygien
habit
qualiti
water
suppli
similar
trend
decreas
intestin
pathogen
period
qu
et
al
epidem
sar
peopl
ate
fewer
sonnei
case
occur
compar
year
indic
eat
main
caus
sonnei
infect
anoth
relat
reason
might
much
fewer
patient
diarrhea
desir
go
hospit
decreas
chanc
acquir
lethal
sar
infect
anoth
import
find
sonnei
replac
flexneri
becom
predomin
subgroup
caus
shigellosi
beij
area
similar
trend
pattern
report
industri
countri
bonfiglio
et
al
ekdahl
andersson
fillioltoutain
et
al
gupta
et
al
ozmert
et
al
emerg
drugresist
multidrugresist
sonnei
strain
becom
import
issu
complic
select
empir
agent
treatment
shigellosi
identifi
monitor
local
resist
pattern
sonnei
provid
effect
empir
treatment
regimen
resist
rate
singleand
multidrug
resist
sonnei
isol
beij
higher
report
develop
develop
countri
ozmert
et
al
pourakbari
et
al
talukd
et
al
wong
et
al
wu
et
al
studi
result
reveal
drug
resist
occur
antibiot
test
sonnei
countri
huang
et
al
jain
et
al
lartigu
et
al
nagano
et
al
vinh
et
al
vrint
et
al
multidrugresist
sonnei
isol
resist
rate
sonnei
amp
pip
cro
fep
increas
significantli
studi
period
year
significantli
limit
empir
therapi
capac
shigellosi
area
resist
antimicrobi
agent
increas
constantli
import
survey
monitor
local
resist
order
formul
polici
ration
use
antimicrobi
agent
studi
indic
current
resist
pattern
limit
use
sulfonamid
antibiot
even
though
sxt
amp
pip
current
consid
accept
empir
agent
therapi
shigellosi
develop
countri
accord
resist
result
fluoroquinolon
effect
altern
treat
adult
shigellosi
approv
food
drug
administr
shigellosi
treatment
children
age
less
year
stahlmann
comparison
fosfomycin
good
antibacteri
activ
vitro
low
incid
advers
event
use
altern
treatment
diarrhea
infect
includ
pediatr
patient
fukuyama
et
al
michalopoulo
et
al
chloramphenicol
lower
level
resist
rare
use
diarrhea
patient
clinic
set
advers
effect
arjyal
et
al
use
pfge
character
divers
sonnei
isol
determin
clonal
isol
subtyp
level
studi
previous
report
delapp
et
al
huang
et
al
studi
pfge
genotyp
analysi
sonnei
strain
indic
determin
epidem
clonal
genotyp
subtyp
level
subtyp
domin
one
earli
stage
studi
period
subtyp
start
emerg
increas
significantli
later
year
indic
clonal
transmiss
sonnei
remain
genotyp
level
altern
start
subtyp
level
beij
area
far
limit
data
avail
relationship
genotyp
antimicrobi
resist
profil
sonnei
isol
recov
china
pfge
subtyp
sonnei
isol
chang
studi
period
antimicrobi
resist
rate
statist
differ
among
subtyp
resist
rate
differ
pfge
subtyp
antibiot
vari
especi
antibiot
subtyp
associ
resist
amp
pip
highest
resist
rate
cro
found
higher
level
amp
pip
cro
fep
resist
sonnei
isol
play
import
role
major
clonal
transmiss
beij
risk
factor
relat
sonnei
circul
depart
besid
sex
age
sonnei
becom
domin
shigella
subgroup
caus
gastroenter
beij
area
studi
sonnei
becom
import
due
increas
epidem
frequenc
multiresist
strain
emerg
clonal
transmiss
furthermor
continu
monitor
subgroup
resist
pattern
preval
sonnei
mandatori
appropri
select
empir
antimicrobi
drug
therapi
prevent
emerg
resist
strain
dissemin
resist
gene
